ObjectiveTo investigate the promoting effect of Angelica sinensis on the cortical regeneration of the thymus in mice treated with rapamycin and its preliminary mechanism.MethodsThe chemical components of Angelica sinensis were analyzed using high-resolution liquid chromatography-mass spectrometry (LC-MS) and ultra-performance liquid chromatography (UPLC). Seventy-two 6-8-week-old female BALB/c mice were randomly assigned by weight into six groups (n=12 per group): blank control, model control, normal regeneration, and Angelica sinensis small- (1 g/kg), medium- (2 g/kg), and large-dose (4 g/kg) groups. Except for the blank control group, acute thymic involution was induced in all other groups via intraperitoneal injection of rapamycin (1 mg·kg-1·d-1) for 3 consecutive days. After modeling, the Angelica sinensis-treated groups received oral gavage of corresponding doses for 7 days, while the normal regeneration and blank control groups received an equal volume of saline. Body weight and dorsal hair growth were recorded daily. Forelimb grip strength was measured 2 hours after the last administration. Thymic structure and the spatial distribution of thymic epithelial cells (TEC) and thymocytes were assessed by hematoxylin-eosin (HE) and immunofluorescence staining. Development and homeostasis of T-cell subsets in the thymus and peripheral blood were analyzed by flow cytometry and rapid Wright-Giemsa staining. T-cell receptor excision circles (TRECs) in genomic DNA from peripheral blood mononuclear cells was detected by quantitative PCR (qPCR). The mRNA expression levels of thymic function-related genes, inflammatory factors, and Wnt pathway-related genes were measured by quantitative reverse transcription PCR (qRT-PCR). Potential targets and pathways were screened by integrating network pharmacology prediction and molecular docking.ResultsRapamycin successfully induced acute thymic atrophy. The model control group showed an approximately 50% decrease in thymic index (PPAngelica sinensis dose-dependently increased the cortical area, significantly enhanced the density of cortical CK8+ TECs and restored the continuity of their cytoplasmic process network (PFoxn1 (PDll4. Regarding thymocyte development, Angelica sinensis (large doses) significantly increased the proportion of CD3+TCRβ+ thymocytes (P+CD8+ cells into mature single-positive (SP) thymocytes, and re-established normal spatial localization, manifested as increased density of CD8+ and CD4+CD8+ cells in the cortex and re-aggregation of TCRβ+ cells in the medulla. Furthermore, Angelica sinensis (medium dose) significantly reduced the mRNA levels of thymic pro-inflammatory factors TNF-α, TGF-β, and IGFBP5 (PAngelica sinensis intervention maintained and increased the proportion of peripheral blood CD3+ T cells, elevated the percentage of CD34+ hematopoietic stem cells across all dosage groups (PCcl25. Mechanistically, network pharmacology predicted Wnt pathway as a potential target of Angelica sinensis active components. Experimental validation revealed that Angelica sinensis (medium dose) significantly upregulated Wnt4 mRNA expression, inhibited Gsk3β, and increased CTNNB1 (β-catenin) levels in the thymus (PConclusionAngelica sinensis promotes cortical regeneration and functional recovery after rapamycin-induced acute thymic involution by activating the Wnt/CTNNB1/Foxn1 signaling pathway and improving the thymic inflammatory microenvironment, which collaboratively facilitate cortical thymic epithelial cell cytoskeletal repair and hematopoietic stem cell homing. This suggests its potential benefit against immune aging.
XU et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: